Aska Biotech
Generated 5/4/2026
Executive Summary
Aska Biotech is a German contract development and manufacturing organization (CDMO) established in 2003, specializing in custom production of antibodies, recombinant proteins, and diagnostic immunoassays. Based in Hennigsdorf near Berlin, the company operates under ISO 13485 certification and focuses on providing IVDR-compliant raw materials and solutions for the in vitro diagnostics (IVD) industry, research institutions, and biotech startups. With over two decades of experience, Aska Biotech has positioned itself as a reliable partner in the biologics and diagnostic supply chain, serving a growing European market that demands high-quality, regulatory-compliant reagents. The company’s private status and steady regional presence suggest a stable, niche operation with potential for targeted growth, particularly as the IVD sector expands due to increased diagnostic testing and regulatory harmonization. While financial details remain undisclosed, Aska Biotech’s long-standing track record and certifications indicate a solid foundation for capturing new business opportunities.
Upcoming Catalysts (preview)
- Q4 2026New IVDR certification or partnership with a diagnostic firm65% success
- Q3 2026Expansion of production capacity or facility upgrade55% success
- TBDMajor contract win with a biotech or pharmaceutical company50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)